Journal of Shandong University (Health Sciences) ›› 2024, Vol. 62 ›› Issue (9): 30-35.doi: 10.6040/j.issn.1671-7554.0.2024.0375

• Advances in Basic and Clinical Research on Aortic Diseases-Research Progress • Previous Articles    

Progress in diagnosis and treatment of immune disease related aortic lesions

GAO Jianfeng1, LI Fangda1, WU Lianglin1, ZENG Rong1, ZHENG Yuehong1,2   

  1. 1. Department of Vascular Surgery;
    2. State Key Laboratory of Complex Severe and Rare Diseases, Peking Union Medical College Hospital, Chinese Academy of Medical Science and Peking Union Medical College, Beijing 100730, China
  • Published:2024-10-10

PDF (PC)

4

Abstract: Immune-related aortic disease has always been a challenging lesion in vascular surgery, characterized by obstructive or dilated lesions in the aorta, leading to ischemia of organs and limbs, as well as the high mortality risk from aneurysm rupture. Previously, there was a lack of specificity in the diagnosis of the immune diseases that cause such aortic lesions, which may result in deficiencies in the comprehensive management of the disease. With the development of medical science, the management of this disease has been significantly improved, but its research progress still needs to be systematically summarized. This review aims to conclude the current status of the management for common immune-related aortic diseases(Takayasus aortitis, giant cell arteritis, Behcets arteritis)from diagnosis and therapy perspectives, and to provide recommendations for different types of aortic lesions, as well as to guide clinical work and future development in this field.

Key words: Aortic disease, Immunological disease, Open surgery, Endovascular revascularization

CLC Number: 

  • R654.3
[1] Kadian-Dodov D, Seo P, Robson PM,et al. Inflammatory diseases of the aorta: JACC focus seminar, part 2[J]. J Am Coll Cardiol, 2022, 80(8): 832-844.
[2] Gravanis MB. Giant cell arteritis and Takayasu aortitis: morphologic, pathogenetic and etiologic factors[J]. Int J Cardiol, 2000, 75(1): 21-33.
[3] Saadoun D, Vautier M, Cacoub P. Medium- and large-vessel vasculitis[J]. Circulation, 2021, 143(3): 267-282.
[4] Zhang X, Li Y, Zheng YH. Diffuse aortoiliac occlusion with formation of extensive collateral circulation in Takayasus arteritis[J]. Eur Heart J, 2019, 40(41): 3439. doi:10.1093/eurheartj/ehz289.
[5] Joseph G, Goel R, Thomson VS, et al. Takayasu arteritis: JACC focus seminar 3/4[J]. J Am Coll Cardiol, 2022: S0735-S1097(22)07305-3. doi:10.1016/j.jacc.2022.09.051.
[6] Soulages A, Sibon I, Vallat JM, et al. Neurologic manifestations of giant cell arteritis[J]. J Neurol, 2022, 269(7): 3430-3442.
[7] Kaymakci MS, Boire NA, Bois MC, et al. Persistent aortic inflammation in patients with giant cell arteritis[J]. Autoimmun Rev, 2023, 22(9): 103411. doi:10.1016/j.autrev.2023.103411.
[8] Ishikawa K. Diagnostic approach and proposed criteria for the clinical diagnosis of Takayasus arteriopathy[J]. J Am Coll Cardiol, 1988, 12(4): 964-972.
[9] de Souza AWS, de Carvalho JF. Diagnostic and classification criteria of Takayasu arteritis[J]. J Autoimmun, 2014, 48/49: 79-83. doi:10.1016/j.jaut.2014.01.012.
[10] Ponte C, Grayson PC, Robson JC, et al. 2022 American College of Rheumatology/EULAR classification criteria for giant cell arteritis[J]. Ann Rheum Dis, 2022, 81(12): 1647-1653.
[11] Ben-Shoshan J, Zahler D, Steinvil A, et al. Extracranial carotid artery stenosis and outcomes of patients undergoing transcatheter aortic valve replacement[J]. Int J Cardiol, 2017, 227: 278-283. doi:10.1016/j.ijcard.2016.11.107.
[12] Li J, Wang YH, Wang YH, et al. Association between acute phase reactants, interleukin-6, tumor necrosis factor-α, and disease activity in Takayasus arteritis patients[J]. Arthritis Res Ther, 2020, 22(1): 285. doi:10.1186/s13075-020-02365-y.
[13] Andel PM, Chrysidis S, Geiger J, et al. Diagnosing giant cell arteritis: a comprehensive practical guide for the practicing rheumatologist[J]. Rheumatol Oxf Engl, 2021, 60(11): 4958-4971.
[14] Quinn KA, Ahlman MA, Malayeri AA, et al. Comparison of magnetic resonance angiography and 18F-fluorodeoxyglucose positron emission tomography in large-vessel vasculitis[J]. Ann Rheum Dis, 2018, 77(8): 1165-1171.
[15] Bardi M, Diamantopoulos AP. EULAR recommendations for the use of imaging in large vessel vasculitis in clinical practice summary[J]. Radiol Med, 2019, 124(10): 965-972.
[16] 蔡丹杰, 迪丽比热·阿迪力, 石洪成. 18F-FDG全身PET/CT 2小时显像探测大动脉炎病灶的价值[J]. 中华核医学与分子影像杂志, 2022, 42(8): 462-466. CAI Danjie, Dilibire Adili, SHI Hongcheng. Value of 18F-FDG total-body PET/CT 2-hour imaging in detection of Takayasu arteritis[J]. Chinese Journal of Nuclear Medicine and Molecular Imaging, 2022, 42(8): 462-466.
[17] Badawi RD, Shi HC, Hu PC, et al. First human imaging studies with the EXPLORER total-body PET scanner[J]. J Nucl Med, 2019, 60(3): 299-303.
[18] 姜林娣,马莉莉,薛愉,等.大动脉炎诊疗规范[J].中华内科杂志, 2022, 61(5): 517-524. JIANG Lindi, MA Lili, XUE Yu, et al. Recommendations of diagnosis and treatment of Takayasus arteritis in China[J]. Chinese Journal of Internal Medicine, 2022, 61(5): 517-524.
[19] Monti S, águeda AF, Luqmani RA, et al. Systematic literature review informing the 2018 update of the EULAR recommendation for the management of large vessel vasculitis: focus on giant cell arteritis[J]. RMD Open, 2019, 5(2): e001003. doi:10.1136/rmdopen-2019-001003.
[20] Hellmich B, Agueda A, Monti S, et al. 2018 Update of the EULAR recommendations for the management of large vessel vasculitis[J]. Ann Rheum Dis, 2020, 79(1): 19-30.
[21] Maz M, Chung SA, Abril A, et al. 2021 American College of Rheumatology/Vasculitis Foundation Guideline for the management of giant cell arteritis and takayasu arteritis[J]. Arthritis Rheumatol, 2021, 73(8): 1349-1365.
[22] Kwon OC, Oh JS, Park MC, et al. Statins reduce relapse rate in Takayasu arteritis[J]. Int J Cardiol, 2019, 287: 111-115. doi:10.1016/j.ijcard.2019.02.046.
[23] Espitia O, Bruneval P, Assaraf M, et al. Long-term outcome and prognosis of noninfectious thoracic aortitis[J]. J Am Coll Cardiol, 2023, 12, 82(11): 1053-1064.
[24] Chaigne-Delalande S, de Menthon M, Lazaro E, et al. Giant-cell arteritis and Takayasu arteritis: epidemiological, diagnostic and treatment aspect s[J]. Presse Med, 2012, 41(10): 955-65.
[25] Peng M, Ji W, Jiang X, et al. Selective stent placement versus balloon angioplasty for renovascular hypertension caused by Takayasu arteritis: Two-year results[J]. Int J Cardiol, 2016, 15, 205: 117-123. doi:10.1016/j.ijcard.2015.12.006.
[26] Gülcü A, Gezer NS, Akar S, et al. Long-term follow-up of endovascular repair in the management of arterial stenosis caused by Takayasus arteritis[J]. Ann Vasc Surg, 2017, 42: 93-100. doi:10.1016/j.avsg.2016.10.066.
[27] Jung JH, Lee YH, Song GG, et al. Endovascular versus open surgical intervention in patients with Takayasus arteritis: a meta-analysis[J]. Eur J Vasc Endovasc Surg, 2018, 55(6): 888-899.
[28] Isselbacher EM, Preventza O, Hamilton Black J 3rd, et al. 2022 ACC/AHA guideline for the diagnosis and management of aortic disease: a report of the American Heart Association/American College of Cardiology Joint Committee on clinical practice guidelines[J]. Circulation, 2022, 146(24): e334-e482.
[29] Mirouse A, Biard L, Comarmond C, et al. Overall survival and mortality risk factors in Takayasus arteritis: a multicenter study of 318 patients[J]. J Autoimmun, 2019, 96: 35-39. doi:1016/j.jaut.2018.08.001.
[30] Saadoun D, Lambert M, Mirault T, et al. Retrospective analysis of surgery versus endovascular intervention in Takayasu arteritis: a multicenter experience[J]. Circulation, 2012, 125(6): 813-819.
[31] Joseph G, Thomson VS, Attumalil TV, et al. Outcomes of percutaneous intervention in patients with Takayasu arteritis[J]. J Am Coll Cardiol, 2023, 81(1): 49-64.
[32] Espitia O, Bruneval P, Assaraf M, et al. Long-term outcome and prognosis of noninfectious thoracic aortitis[J]. J Am Coll Cardiol, 2023, 82(11): 1053-1064.
[33] Wu L, Li F, Sun X, et al. Long term outcomes and potential risk factors for endovascular repair of aortic pseudoaneurysms in vascular Behçets disease[J]. Eur J Vasc Endovasc Surg, 2023, 66(2): 169-177.
[34] International Study Group for Behçets Disease. Criteria for diagnosis of Behçets disease [J]. Lancet, 1990, 335(8697): 1078-1080.
[35] Kwon TW, Park SJ, Kim HK, et al. Surgical treatment result of abdominal aortic aneurysm in Behçets disease[J]. Eur J Vasc Endovasc Surg, 2008, 35(2): 173-180.
[36] Mousa A, Hanbal I, Sharabi A, et al. Vascular suture line wrapping for Aortoiliac anastomoses following open surgical repair of Infrarenal Behçets Aortoiliac aneurysms[J]. Orphanet J Rare Dis, 2019, 14(1): 81. doi:10.1186/s13023-019-1048-y.
[1] . [J]. JOURNAL OF SHANDONG UNIVERSITY (HEALTH SCIENCES), 2016, 54(3): 91-94.
[2] LI Zi, ZHANG Xuping, JIAO Haimiao, LIU Luqi. Detection of cross-linking degree in artificial aeart valves with amine-specific fluorescent probe [J]. JOURNAL OF SHANDONG UNIVERSITY (HEALTH SCIENCES), 2014, 52(12): 1-4.
[3] ZHANG Xu-ping, ZHANG Dong, LI Zi, LIU Lu-qi. Research on the relationship between diabetes mellitus and in-situ saphenous vein disease [J]. JOURNAL OF SHANDONG UNIVERSITY (HEALTH SCIENCES), 2013, 51(11): 66-70.
[4] ZHANG Dong, ZHANG Jun, LIU Lu-qi. Research on the properties of allogenic arteries cross-linked by
dye-mediated photooxidation and Genipin [J]. JOURNAL OF SHANDONG UNIVERSITY (HEALTH SCIENCES), 2012, 50(10): 41-.
[5] ZHONG Zhen-yue , WANG Mo, GAO Bin-bin, DONG Dian-ning, ZHANG Shi-yi , SUN Yan. Experience of emergency surgery on ruptured abdominal aortic aneurysm（a report of 19 Cases） [J]. JOURNAL OF SHANDONG UNIVERSITY (HEALTH SCIENCES), 2010, 48(8): 111-.
[6] . Outcome of surgical repair with a stented elephant 
trunk for aortic dissection [J]. JOURNAL OF SHANDONG UNIVERSITY (HEALTH SCIENCES), 2009, 47(10): 91-93.
[7] GU Zhi-tao,LIU Lu-qi. Anti-calcification function property of allogenic arteries cross-linked by dye0mediated photooxidation [J]. JOURNAL OF SHANDONG UNIVERSITY (HEALTH SCIENCES), 2007, 45(10): 1050-1053.
[8] GAN Qiqing, LIU Xianhu, GOU Yuan, YANG Bin. Diagnosis and treatment of aortic dissection combined with paraplegia: a report of two cases and literature review [J]. Journal of Shandong University (Health Sciences), 2024, 62(8): 101-106.
[9] LIN Changpo, FU Weiguo. Progress in diagnosis and treatment of Stanford type B aortic dissection [J]. Journal of Shandong University (Health Sciences), 2024, 62(9): 7-12.
[10] WANG Lunchang, QIN Qi, SHU Chang. Advances in diagnosis and treatment of traumatic type B aortic dissection [J]. Journal of Shandong University (Health Sciences), 2024, 62(9): 19-25.
[11] WANG Zhenhua, SONG Han,WEI Duoliang, LI Bowen, XU Kai, FANG Changcun, ZHAO Xin. Early remodeling of the proximal aorta after Castor single-branched stent-graft implantation for acute type B aortic dissection [J]. Journal of Shandong University (Health Sciences), 2023, 61(2): 36-42.
Viewed
Full text


Abstract

Cited
  Shared   
  Discussed   
No Suggested Reading articles found!
Copyright 2018 © Editorial office of Journal of Shandong University (Health Sciences)
Supported by Beijing Magtech Co.Ltd